Puig N, Contreras MT, Agullo C, Martinez-Lopez J, Oriol A, Blanchard MJ, Rios R, Martin J, Inigo MB, Sureda A, Hernandez MT, de la Rubia J, Gonzalez-Calle V, Krsnik I, Cabanas V, Palomera L, Moraleda JM, Bargay J, Cedena MT, Paiva B, Rosinol L, Blade J, San Miguel J, Lahuerta JJ, Mateos MV. Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma. Blood Adv. 2022 Jun 14;6(11):3234-3239. doi: 10.1182/bloodadvances.2021006762. PubMed PMID: 35157768; PubMed Central PMCID: PMC9198943.
AÑO: 2022; IF: 7.5
|
Poveda, EF; Cabanas-Perianes, V; Sanchez-Salinas, A; Blanquer-Blanquer, M; Berenguer-Piqueras, M; Moya-Arna, M; Martinez-Marin, A; Moraleda-Jimenez, JM. RESULTS OF THE IMPLEMENTATION OF CRYOTHERAPY IN PROTOCOLS OF ORAL MUCOSITIS PROPHYLAXIS IN PATIENTS SUBJECT TO A TRASPLANT OF HEMATOPOYETIC PROGENITORS. EXPERIENCE OF ONE CENTER. HAEMATOLOGICA. 2017; 102:636-636.
AÑO: 2017; IF: 11.047
|
Fuster, JL; Cabanas, V; Blanquer, M; Sanchez-Salinas, A; Monserrat-Coll, J; Pascual-Gaquez, JF; Galera, A; Llinares, E; Bermudez-Cortes, M; Moraleda, JM. THE RECENT SINGLE CENTRE EXPERIENCE WITH PEDIATRIC SOLID TUMORS OF A NEW STEM CELL TRANSPLANTATION AND CELL THERAPY UNIT. BONE MARROW TRANSPLANTATION. 2014; 49:S366-S366.
AÑO: 2014; IF: 5.174
|
Oliver-Caldes A, Espanol-Rego M, Zabaleta A, Gonzalez-Calle V, Navarro-Velazquez S, Inoges S, de Cerio AL, Cabanas V, Lopez-Munoz N, Rodriguez-Otero P, Reguera JL, Moreno DF, Martinez-Cibrian N, Lopez-Corral L, Perez-Amill L, Martin-Antonio B, Rosinol L, Cid J, Tovar N, Saez-Penataro J, Lopez-Parra M, Olesti E, Guillen E, Varea S, Rodriguez-Lobato LG, Battram AM, Gonzalez MS, Sanchez-Salinas A, Gonzalez-Navarro A, Ortiz-Maldonado V, Delgado J, Prosper F, Juan M, Martinez-Lopez J, Moraleda JM, Mateos MV, Urbano-Ispizua A, Paiva B, Pascal M, Fernandez de Larrea C. Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma. Clin Cancer Res. 2024 May 15;30(10):2085-2096. doi: 10.1158/1078-0432.CCR-23-3759. PubMed PMID: 38466644.
AÑO: 2024; IF: 10.0
|